Boothbay Fund Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-69,911
| Closed | -$8.09M | – | 1940 |
|
2023
Q3 | $8.09M | Buy |
69,911
+66,551
| +1,981% | +$7.7M | 0.19% | 73 |
|
2023
Q2 | $346K | Sell |
3,360
-81,915
| -96% | -$8.42M | 0.01% | 1055 |
|
2023
Q1 | $9.31M | Sell |
85,275
-6,967
| -8% | -$760K | 0.19% | 72 |
|
2022
Q4 | $10.5M | Buy |
92,242
+9,854
| +12% | +$1.12M | 0.24% | 37 |
|
2022
Q3 | $5.1M | Buy |
82,388
+14,701
| +22% | +$910K | 0.13% | 156 |
|
2022
Q2 | $5.4M | Buy |
67,687
+5,356
| +9% | +$427K | 0.14% | 136 |
|
2022
Q1 | $6.56M | Buy |
62,331
+14,608
| +31% | +$1.54M | 0.15% | 102 |
|
2021
Q4 | $5.14M | Buy |
47,723
+38,477
| +416% | +$4.15M | 0.12% | 146 |
|
2021
Q3 | $1.01M | Sell |
9,246
-6,965
| -43% | -$763K | 0.03% | 603 |
|
2021
Q2 | $1.52M | Buy |
16,211
+11,557
| +248% | +$1.08M | 0.05% | 437 |
|
2021
Q1 | $428K | Sell |
4,654
-15,150
| -76% | -$1.39M | 0.02% | 826 |
|
2020
Q4 | $1.45M | Buy |
+19,804
| New | +$1.45M | 0.05% | 294 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1266 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1113 |
|
2019
Q2 | – | Sell |
-36,227
| Closed | -$957K | – | 915 |
|
2019
Q1 | $957K | Buy |
36,227
+6,227
| +21% | +$164K | 0.09% | 182 |
|
2018
Q4 | $586K | Buy |
+30,000
| New | +$586K | 0.09% | 181 |
|